The role of nebulized beclomethasone dipropionate in the treatment of bronchial asthma

· RAJ №6-2013

Avdeev S.N.

Institute of Pulmonology, Moscow, Russia

Key words: asthma, inhaled corticosteroids, beclomethasone dipropionate, nebulized therapy

Beclomethasone dipropionate (BDP, Clenil UDV) is a well-studied inhaled corticosteroid for the treatment of patients with bronchial asthma (BA). Randomized controlled trials have shown that nebulized therapy with BDP was similar in its efficacy and safety to inhalation therapy with budesonide or fluticasone. Preferred patients for the treatment with nebulized BDP are elderly patients with asthma, unable to correctly perform inhalation with portable devices, patients with steroid-dependent asthma, and patients with a temporary loss of asthma control.